Our Story

32 Biosciences: Transforming Gut Health Through Science and Innovation

32 Biosciences was born out of a groundbreaking vision to redefine healthcare through the power of the gut microbiome. Rooted in over two decades of pioneering research at The University of Chicago and the University of Wisconsin-Madison, our journey began with the collaboration of three world-renowned scientific founders—Dr. John Alverdy, Dr. Gene Chang, and Dr. Joseph Pierre. Together, their insights into the gut microbial organ revealed its pivotal role in human health, inspiring us to develop innovative solutions that address unmet medical needs. Our name, “Three Squared Biosciences,” reflects the exponential impact of our founders’ collaboration and their shared commitment to advancing microbiome science. Today, we are at the forefront of microbiome-based diagnostics and interventions, translating cutting-edge research into transformative healthcare solutions.

Our Vision

At 32 Biosciences, we envision a world where the gut microbiome is recognized as a cornerstone of health, transforming healthcare into a proactive pursuit of longevity and vitality. Through pioneering science and innovative solutions, we aim to redefine healthspan and empower individuals to thrive.
Medical Researcher looking through a microscope.
Image of a gut, with wordse 'Focus on the Gut Microbiome to Prevent and Treat Disease' around it.

Our Mission

Our mission is to transform healthcare by redefining and restoring the functional health of the gut microbiome, which we recognize as a vital organ. Through our innovative diagnostic management tools and microbiome-based interventions, we aim to improve health span and longevity, prevent and treat chronic diseases, and shift the focus from sick care to true healthcare.